Skip to content

DR. PLASMANS

Active
Private limited companyfounded 20169 yrs activeDe Neufstraat 43, 2100 Antwerpen, BelgiumKBO/BCE: BE 0665.813.047
Summary

DR. PLASMANS has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €243,240 and a net result of €95,956. Equity is growing by ~9.5% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 1.0% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability92▲+4
Solvency72▼-28
Growth81=
Track record100
Bankruptcy probability, 12 months
1.0% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18,000 at 30 days acceptable
Liquidity ample (current ratio 1.84 against 7.07 in 2024; short-term debt: 53.2% and cash: 88.6% of total assets), but 53.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Three signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
46.8%
Return on assets
18.5%
Age of the figures
9 mo
neutral · A punctual record breaks
This company filed 8 consecutive financial years on time. The year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 9 filings
Deviation from the deadline
2025
31 d late
2024
5 d early
2023
85 d early
2022
84 d early
2021
58 d early
2020
31 d early
2019
87 d early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 46 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 3 June (4 of the last 5 filed years within 53 days of that day).
Companies Code · seven months
Position in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 8 November 2016, DR. PLASMANS was incorporated.1 Total assets went from EUR 176,541 in 2018 to EUR 519,618 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Turnover
€196,436▲ 16.2%
2018 · €169,098
EBIT margin
58.2%▲ 3.1pp
2018 · 55.1%
Net result
€95,956▲ 37.5%
2024 · €69,797
Working capital
€231,434▼ 37.7%
2024 · €371,753
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Turnover
Operating result€139,570▲ 16.5%€98,180▼ 29.7%€90,472▼ 7.9%€101,609▲ 12.3%€139,671▲ 37.5%
Net result€98,305▲ 16.2%€68,957▼ 29.9%€63,227▼ 8.3%€69,797▲ 10.4%€95,956▲ 37.5%
EBIT margin
Equity€377,957▲ 35.2%€381,615▲ 1.0%€378,053▼ 0.9%€399,135▲ 5.6%€243,240▼ 39.1%
Total assets€397,549▲ 24.9%€462,431▲ 16.3%€462,773▲ 0.1%€460,402▼ 0.5%€519,618▲ 12.9%
Debt€19,592▼ 49.2%€80,816▲ 312%€84,720▲ 4.8%€61,266▼ 27.7%€276,378▲ 351%
Working capital€312,949▲ 14.7%€322,961▲ 3.2%€335,094▲ 3.8%€371,753▲ 10.9%€231,434▼ 37.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50,000€100,000€150,000Operating result 2021: €139,570€139,570Net result 2021: €98,305€98,305Operating result 2022: €98,180€98,180Net result 2022: €68,957€68,957Operating result 2023: €90,472€90,472Net result 2023: €63,227€63,227Operating result 2024: €101,609€101,609Net result 2024: €69,797€69,797Operating result 2025: €139,671€139,671Net result 2025: €95,956€95,95620212022202320242025€0€50,000€100,000€150,000Operating result 2023: €90,472€90,500Net result 2023: €63,227€63,200Operating result 2024: €101,609€102,000Net result 2024: €69,797€69,800Operating result 2025: €139,671€140,000Net result 2025: €95,956€96,000202320242025
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 37% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €519,618
Fixed assets €11,806 ▼ 56.9%
Current assets €507,812 ▲ 17.3%
Equity and liabilities €519,618
Equity €243,240 ▼ 39.1%
Debt €276,378 ▲ 351%
Debt's share of the balance-sheet total rises from 13.3% to 53.2%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€155,248▲
2024 · €117,186
Cash flow
€111,533▲
2024 · €85,374
Current ratio
1.84▼
2024 · 7.07
Debt to equity
1.14▲
2024 · 0.15
ROE
39.4%▲
2024 · 17.5%
ROA
18.5%▲
2024 · 15.2%
Interest coverage
2155.33▲
2024 · 261.28
Debt ≤ 1 year
€276,378▲
2024 · €61,266
Income taxes
€43,643▲
2024 · €31,371
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 6,781 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 97% are still going.

  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.6% went bankrupt
2.7% stopped otherwise
97% still going

For this company itself Checked computes a higher bankruptcy probability: 1.0% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.9%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 6,781 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet Code20242025
Assets
Total assets20/58€460,402€519,618▲
Fixed assets21/28€27,383€11,806▼
Tangible fixed assets22/27€27,383€11,806▼
Furniture and vehicles24€27,383€11,806▼
Current assets29/58€433,019€507,812▲
Amounts receivable after more than one year29€0-
Other amounts receivable291€0-
Amounts receivable within one year40/41€63,661€46,976▼
Trade receivables40€63,661€46,976▼
Other amounts receivable41€0-
Cash at bank and in hand54/58€369,017€460,439▲
Deferred charges and accrued income490/1€341€397▲
Equity and liabilities
Total equity and liabilities10/49€460,402€519,618▲
Equity10/15€399,135€243,240▼
Contributions10/11€12,400€12,400=
Reserves13€386,735€230,840▼
Distributable reserves133€386,735€230,840▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€61,266€276,378▲
Amounts payable within one year42/48€61,266€276,378▲
Trade debts44€221€234▲
Suppliers440/4€221€234▲
Taxes, remuneration and social security45€7,807€36,519▲
Taxes450/3€7,807€33,519▲
Remuneration and social security454/9-€3,000
Other amounts payable47/48€53,239€239,624▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15,577€15,577=
Other operating charges640/8€3,288€2,282▼
Gross operating margin9900€120,474€157,530▲
Operating profit (loss)9901€101,609€139,671▲
Financial income75/76B€8€0▼
Recurring financial income75€8€0▼
Financial charges65/66B€449€72▼
Recurring financial charges65€449€72▼
Profit (loss) for the period before taxes9903€101,168€139,599▲
Income taxes67/77€31,371€43,643▲
Profit (loss) for the period9904€69,797€95,956▲
Profit (loss) for the period to be appropriated9905€69,797€95,956▲
Appropriation of the result
Profit (loss) to be appropriated9906€69,797€95,956▲
Transfer from equity791/2€48,715€251,852▲
Transfer to equity691/2€69,797€95,956▲
To other reserves6921€69,797€95,956▲
Profit to be distributed694/7€48,715€251,852▲
Return on contributions (dividend)694€48,715€251,852▲

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Non-recurring operating income76A€10,790€0----
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7,413€14,868€15,694€15,577€15,577=
Other operating charges640/8€6,511€1,121€1,777€3,288€2,282▼ 30.6%
Non-recurring operating charges66A€0-----
Gross operating margin9900€153,494€114,169€107,944€120,474€157,530▲ 30.8%
Operating profit (loss)9901€139,570€98,180€90,472€101,609€139,671▲ 37.5%
Financial income75/76B€701€700€600€8€0▼ 100%
Recurring financial income75€701€700€600€8€0▼ 100%
Financial charges65/66B€115€70€72€449€72▼ 83.9%
Recurring financial charges65€115€70€72€449€72▼ 83.9%
Profit (loss) for the period before taxes9903€140,157€98,809€91,001€101,168€139,599▲ 38.0%
Income taxes67/77€41,852€29,853€27,774€31,371€43,643▲ 39.1%
Profit (loss) for the period9904€98,305€68,957€63,227€69,797€95,956▲ 37.5%
Profit (loss) for the period to be appropriated9905€98,305€68,957€63,227€69,797€95,956▲ 37.5%
Line20212022202320242025Change
Assets
Total assets20/58€397,549€462,431€462,773€460,402€519,618▲ 12.9%
Fixed assets21/28€65,008€58,654€42,960€27,383€11,806▼ 56.9%
Tangible fixed assets22/27€65,008€58,654€42,960€27,383€11,806▼ 56.9%
Furniture and vehicles24€65,008€58,654€42,960€27,383€11,806▼ 56.9%
Current assets29/58€332,541€403,777€419,814€433,019€507,812▲ 17.3%
Amounts receivable after more than one year29€70,000€70,000€60,000€0--
Other amounts receivable291€70,000€70,000€60,000€0--
Amounts receivable within one year40/41€47,520€74,043€72,772€63,661€46,976▼ 26.2%
Trade receivables40€43,542€67,896€72,624€63,661€46,976▼ 26.2%
Other amounts receivable41€3,978€6,147€147€0--
Cash at bank and in hand54/58€215,021€253,749€285,765€369,017€460,439▲ 24.8%
Deferred charges and accrued income490/1€0€5,985€1,277€341€397▲ 16.6%
Equity and liabilities
Total equity and liabilities10/49€397,549€462,431€462,773€460,402€519,618▲ 12.9%
Equity10/15€377,957€381,615€378,053€399,135€243,240▼ 39.1%
Contributions10/11€12,400€14,260€14,260€12,400€12,400=
Reserves13€365,557€367,355€363,793€386,735€230,840▼ 40.3%
Non-distributable reserves130/1€1,860€0----
Reserves not available under the articles1311€1,860€0----
Distributable reserves133€363,697€367,355€363,793€386,735€230,840▼ 40.3%
Profit (loss) carried forward14-€0€0€0€0-
Amounts payable17/49€19,592€80,816€84,720€61,266€276,378▲ 351%
Amounts payable within one year42/48€19,592€80,816€84,720€61,266€276,378▲ 351%
Trade debts44€5,587€5,017€1,961€221€234▲ 6.0%
Suppliers440/4€5,587€5,017€1,961€221€234▲ 6.0%
Taxes, remuneration and social security45€14,005€10,564€13,288€7,807€36,519▲ 368%
Taxes450/3€14,005€10,564€13,288€7,807€33,519▲ 329%
Remuneration and social security454/9----€3,000-
Other amounts payable47/48-€65,235€69,472€53,239€239,624▲ 350%
Accrued charges and deferred income492/3€0-----
Line20212022202320242025Change
Profit (loss) for the period9904€98,305€68,957€63,227€69,797€95,956▲ 37.5%
+ Depreciation and write-downs630€7,413€14,868€15,694€15,577€15,577=
Operating cash flow (approximation)€105,718€83,825€78,921€85,374€111,533▲ 30.6%
Investment in fixed assets (approximation)--€8,514€0€0€0-
Change in cash-€38,729€32,016€83,252€91,422▲ 9.8%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
31-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
26-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
07-05
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Weakest financial yearnet €63,227 ▼8.3%
Net result drops to €63,227, the lowest in the series; recovery starts the following year.
08-05
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
03-06
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial Highest result since 2018net €98,305 ▲16.2%
Net result €98,305, the highest in the series.
31-12
Financial Liquidity doublescurrent ratio 16.97
Current ratio from 8.19 to 16.97; short-term debt falls from €37,983 to €19,592.
30-06
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Liquidity doublescurrent ratio 8.19
Current ratio from 3.59 to 8.19; short-term debt falls from €69,762 to €37,983.
31-12
Financial Equity above €200,000Eq €279,653 ▲43.4%
3 profitable years in a row build equity to €279,653.
05-05
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
Show earlier events
2019
31-12
Financial Equity above €150,000Eq €195,062 ▲33.3%
2 profitable years in a row build equity to €195,062.
24-05
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
05-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts

We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2016
seat establishment The establishment unit on the map
Ground area
700 m²
Building footprint
182 m²
Volume, LiDAR
1,377 m³
2 parcels, Flanders · tallest building 13.0 m, ±3 floors. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
Jacobuslei 79, 2930 Brasschaat
Specialist medical practice
since 20162.262.618.139
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11323F0060/00C010 Flanders 525 m² 1 · 101 m² 13.0 m · 2 fl.
11344A0531/00L007 Flanders 176 m² 1 · 81 m² 10.3 m · 3 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company
Founded08-11-2016
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:0665813047
Registered 10-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.